No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹1,026.2Prev. Close
₹1,052.5Turnover(Lac.)
₹20,720.91Day's High
₹1,026.2Day's Low
₹90352 Week's High
₹1,08552 Week's Low
₹545.5Book Value
₹149.83Face Value
₹2Mkt Cap (₹ Cr.)
7,382.28P/E
40.27EPS
26.03Divi. Yield
0.1No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 16.1 | 16.1 | 16.1 | 16.1 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 980.66 | 799.27 | 683.36 | 599.59 |
Net Worth | 996.76 | 815.37 | 699.46 | 615.69 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 |
|---|---|
Revenue | 385.36 |
yoy growth (%) | |
Raw materials | -128.12 |
As % of sales | 33.24 |
Employee costs | -32.76 |
| Y/e 31 Mar( In .Cr) | Mar-2021 |
|---|---|
Profit before tax | 167.31 |
Depreciation | -6.76 |
Tax paid | -43.71 |
Working capital | |
Other operating items |
| Y/e 31 Mar | Mar-2021 |
|---|---|
Growth matrix (%) | |
Revenue growth | |
Op profit growth | |
EBIT growth | |
Net profit growth |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,789.9 | 143.08 | 4,29,468.96 | 608.7 | 0.89 | 4,887.27 | 93.23 |
Divis Laboratories Ltd DIVISLAB | 6,533 | 65.09 | 1,73,304.53 | 756 | 0.46 | 2,793 | 629.49 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,317.9 | 65.05 | 1,46,013.82 | 467 | 0 | 2,677 | 249.73 |
Cipla Ltd CIPLA | 1,379.3 | 30.1 | 1,11,387.62 | 384.64 | 0.94 | 3,840.92 | 423.38 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,078.3 | 29.35 | 1,08,396.56 | 1,722 | 0.09 | 3,564.6 | 235.25 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman / Executive Director / Managing Director
Satish Waman Wagh
E D & Wholetime Director
Smita Satish Wagh
E D & Wholetime Director
Saloni Satish Wagh
E D & Wholetime Director
Shivani Satish Wagh
E D & Wholetime Director
Balasaheb G. Sawant
Independent Non Exe. Director
Neelam Yashpal Arora
Independent Non Exe. Director
Ganapati D Yadav
Independent Non Exe. Director
Sunil Subhash Bhagwat
Company Sec. & Compli. Officer
Prachi Sathe
Additional Independent Director
MANISH ISHWARLAL PANCHAL
Additional Independent Director
Kothandaraman Hari
207/208 Udyog Bhavan,
Sonawala Road Goregaon (East),
Maharashtra - 400063
Tel: 91-22-40332727
Website: http://www.supriyalifescience.com
Email: cs@supriyalifescience.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: https://in.mpms.mufg.com
Email: rnt.helpdesk@in.mpms.mufg.com
Summary
Supriya Lifescience Limited was initially constituted on October 29, 1985, as a Partnership Firm under the name M/s Supriya Chemicals. The Partnership Firm was last re-constituted pursuant to a Partne...
Read More
Reports by Supriya Lifescience Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.